MARY MORGAN: Open Payments
NPI 1437381209 · MERRIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 24 payments from 11 companies in 2025. Trend: 2023 $342 · 2024 $174 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $395 |
| PFIZER INC. | 4 | $171 |
| Corcept Therapeutics | 4 | $75 |
| Lilly USA, LLC | 2 | $59 |
| ABBVIE INC. | 2 | $52 |
| Novo Nordisk Inc | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| Viatris Specialty LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: BREZTRI, ZAVZPRET, FARXIGA, Korlym, ZEPBOUND, NURTEC ODT, UBRELVY, Ozempic.
Industry payments across ID — which companies pay providers there.
